Mode
Text Size
Log in / Sign up
N/A N=40 Randomized Double-blind Treatment

tAVNS for Stress Reduction in University Students

Psychological Distress · Stress (Psychology) · Perceived Stress

Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcome: Primary: Psychological Distress (K10) — 30.30; 29.5; 27.20; 27.10 Scores on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
taVNS (Device); Sham (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Egas Moniz - Cooperativa de Ensino Superior, CRL
Primary completion
Mar 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Psychological Distress (K10)
30.30; 29.5; 27.20; 27.10; 24.15; 23.40
PRIMARY
Perceived Stress (PSS-10)
24.05; 23.60; 21.85; 21.35; 19.40; 18.95
PRIMARY
Feasibility (Retention Rate)
20; 20
PRIMARY
Tolerability (Adverse Events / Dropout Due to AEs)
0; 0

Summary

The goal of this clinical trial is to learn if transcutaneous auricular vagus nerve stimulation (taVNS) works to reduce perceived stress and psychological distress in university students with high distress levels. The main questions it aims to answer are: * Does taVNS reduce perceived stress (measured by PSS-10) in university students with high psychological distress? * Does taVNS reduce psychological distress (measured by K10) in university students with high psychological distress? * Is the intervention feasible and tolerable for implementation in higher-education mental health support? Researchers will compare taVNS (electrode placed on the left tragus) to a sham stimulation group (electrode placed on the left earlobe) to see if taVNS reduces stress and distress. Participants will: * Attend five consecutive daily 30-minute stimulation sessions * Complete stress and distress questionnaires before the intervention, immediately after, and at 1-month follow-up * Receive electrical stimulation at individually adjusted intensity using the Nurosym device (pulse width 250 µs, frequency 20 Hz).

Eligibility Criteria

Inclusion Criteria

  • Being a university student
  • Age ≥18 years
  • High to very high levels of psychological distress (K10 score ≥22)

Exclusion Criteria

  • Psychotropic medication initiation or dose change within the last 3 months
  • Substance dependence
  • Current psychological or psychotherapeutic treatment
  • Any formal mental disorder diagnosis
  • Pregnancy
  • History of dizziness or seizures
  • Cochlear implants
  • Ear plastic surgery
  • Auricular malformations
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT07411846). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search